Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.
Niederwieser
D
D
Department of Internal Medicine, University Hospital, Innsbruck, Austria.
Arcese
W
W
Bandini
G
G
Schwaighofer
H
H
Thaler
J
J
Bosi
A
A
Di Bartolomeo
P
P
Alessandrino
E P
EP
Urban
C
C
Gratwohl
A
A
D016026:Bone Marrow Transplantation / Q000009:adverse effects; D005240:Feasibility Studies; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy*; D010865:Pilot Projects; D012008:Recurrence
D016898:Interferon-alpha